Pilot study tracks melatonin in pregnancy for future biomarker research
NCT ID NCT03014245
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how melatonin, a hormone known for sleep and as an antioxidant, changes during pregnancy. Researchers measured melatonin and its main byproduct in the blood of 60 women across each trimester. The goal was to gather basic information to help design larger studies on whether melatonin could be a marker for pregnancy complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY TRANSIENT HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aberdeen Maternity Hospital (NHS Grampian)
Aberdeen, Aberdeenshire, AB25 2ZB, United Kingdom